Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Bloqueantes del receptor mineralcorticoide en la enfermedad renal crónica Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;

Cardiovascular and renal outcomes according across to KDIGO stages of chronic kidney disease in the Spanish population: insights from real-world evidence Rafael Santamaria; Carlos Escobar; Unai Aranda; Beatriz Palacios; Margarita Capel; Ignacio Hernández; Ana Cebrián; Roberto Alcázar; Manuel Gorostidi;